Oncology Books

2618 products


  • Bladder Disease

    Springer Bladder Disease

    1 in stock

    Book SynopsisOncology and Cellular Biology.- 1. Recent Developments in the Treatment of Bladder Cancer.- 2. Interferon-? Response and Signal Transduction Pathway in Transitional Carcinoma Cell Lines.- 3. Molecular Cloning and Expression of Uroplakins in Transitional Cell Carcinoma.- 4. Application of a Novel Protein Chip Mass Spectrometry Technology for the Identification of Bladder Cancer-Associated Biomarkers.- 5. The Photodynamic Diagnosis (PDD) for Early Detection of Carcinoma and Dysplasia of the Bladder.- 6. Prediction of Lymph Node Metastasis Based on P53 and nm23-Hl Expression in Muscle Invasive Grade III Transitional Cell Carcinoma of Bladder.- 7. Detection of HER-2/neuCEP 17 Mutations at Invasive Bladder Cancer.- 8. Ki67, P53, nm23, and DNA Cytometry in Bladder Cancer: Potential Markers for Detection of Recurrence.- 9. Comparison of Cytology and Nuclear Matrix Protein 22 (NMP 22) for the Detection and Follow-Up of Bladder Cancer.- 10. The Effect of Contrast Material on Transitional Cell CTable of ContentsOncology and Cellular Biology.- 1. Recent Developments in the Treatment of Bladder Cancer.- 2. Interferon-? Response and Signal Transduction Pathway in Transitional Carcinoma Cell Lines.- 3. Molecular Cloning and Expression of Uroplakins in Transitional Cell Carcinoma.- 4. Application of a Novel Protein Chip Mass Spectrometry Technology for the Identification of Bladder Cancer-Associated Biomarkers.- 5. The Photodynamic Diagnosis (PDD) for Early Detection of Carcinoma and Dysplasia of the Bladder.- 6. Prediction of Lymph Node Metastasis Based on P53 and nm23-Hl Expression in Muscle Invasive Grade III Transitional Cell Carcinoma of Bladder.- 7. Detection of HER-2/neuCEP 17 Mutations at Invasive Bladder Cancer.- 8. Ki67, P53, nm23, and DNA Cytometry in Bladder Cancer: Potential Markers for Detection of Recurrence.- 9. Comparison of Cytology and Nuclear Matrix Protein 22 (NMP 22) for the Detection and Follow-Up of Bladder Cancer.- 10. The Effect of Contrast Material on Transitional Cell Carcinoma Viability.- 11. Fluorodeoxyglucose Positron Emission Tomography Studies in the Diagnosis and Staging of Transitional Cell Carcinoma.- 12. Radiochemotherapy in Locally Invasive Non-Metastatic Carcinoma of the Bladder.- 13. Gene and Antisense Therapy of Bladder Cancer.- 14. Tumor Suppressor Genes of Bladder Cancer and Potential for Gene Therapy.- Muscle, Matrix, and Obstruction.- 15. Molecular Response of the Bladder to Obstruction.- 16. The Role of Lipids and Lipid Metabolites in Urinary Bladder Dysfunction Induced by Partial Outlet Obstruction.- 17. Intercellular Communication and Bladder Function.- 18. Ischemia as an Etiological Factor in Bladder Instability: Implications for Therapy.- 19. Effect of Chronic Ischemia on Bladder Structure and Function.- 20. Ultrastructural Diagnosis of Neuropathic Detrusor Overactivity: Validation of a Common Myogenic Mechanism.- 21. Serial Changes of Smooth Muscle Cell Phenotypes in Rat Urinary Bladder Following Partial Outflow Obstruction.- 22. Study of Detrusor Dysfunction Due to Outlet Obstruction: Link Between Analysis of Uroflows of Men with Benign Prostatic Hyperplasia and Animal Studies.- 23. Ultrasonic Measurement of Bladder Weight as a Novel Urodynamic Modality.- Neurophysiology, Neurogenic Bladder, and Incontinence.- 24. Experimental Neurogenic Cystitis.- 25. Murine In Vitro Whole Bladder Physiology.- 26. Ca2+ Sparks and KCa Channels: Novel Mechanisms to Relax Urinary Bladder Smooth Muscle.- 27. The Effect of Intravesical Capsaicin and Resiniferatoxin in Neurogenic Bladder Dysfunction.- 28. On the Physioanatomy of Micturition and Urinary Continence-New Concepts.- 29. Stress Urinary Incontinence: New Concept of Pathogenesis and Treatment by Pudendal Canal Decompression.- 30. Transcutaneous Electrovesicogram in Normal Volunteers and Patients with Interstitial Cystitis, Neurogenic Bladder, Benign Prostatic Hyperplasia, and after Cystectomy.- 31. Extracorporeal Electromagnetic Stimulation for Urinary Incontinence and Bladder Disease.- 32. Pubovaginal Sling Surgery without Using Abdominal Leak Point Pressure: An Outcomes Analysis.- 33. The Use of Synthetic Materials in Pubovaginal Sling.- 34. Surgical Implantation of the Synthetic Sling (The 6-Point Fixation Technique and Weight-Adjusted Spacing Nomogram): Technique and Results.- 35. Reconstructive Surgery in Neuropathic Bladder.- 36. The Role of the Simple Cystectomy in Urologic Surgery.- Immunology, Inflammation, and Infection.- 37. Neurogenic Inflammation of the Bladder.- 38. Urine-Induced Apoptosis in Cultured Bladder Urothelial Cells.- 39. Bacillus of Calmette and Guerin Modulates Nuclear Factor Kappa ? in Two Urothelial Carcinoma Cell Lines.- 40. Induction of Urothelial Cell Proliferation by Fibroblast Growth Factor-7 in RAG 1-Deficient Mice.- 41. Development of a Recombinant FimCH Vaccine for Urinary Tract Infections.- 42. Intravesicular Pain Mapping.- 43. A Hypothesis for the Etiology of Interstitial Cystitis.- 44. Pentosanpolysulfate (Elmiron) is a Potent Inhibitor of Mast Cell Histamine Secretion.- 45. The Efficacy of Intravesicular Sterile Sodium Chondroitin Sulfate 0.2% in Potassium Tested Positive Patients with Interstitial Cystitis.- 46. Cystectomy Causes Immunosuppression in Bladder Cancer.- New Frontiers and Therapies.- 47. Nocturia.- 48. The Fate of Urinary Bladder Smooth Muscle after Outlet Obstruction—A Role for the Sarcoplasmic Reticulum.- 49. Alteration of Collagen Three-Dimensional Architecture in Noncompliant Human Urinary Bladder.- 50. Modulation of Angiogenesis: Experimental Strategies and Potential Therapeutic Applications.- 51. Methods of Testing Urethral Resistance in the Female Rat.- 52. Virtual Reality Surgical Simulation for Lower Urinary Tract Endourologic Surgery.- 53. Autologous Muscle Transfer for Reconstruction of the Lower Urinary Tract.- 54. Effectiveness of Denuding the Intestinal Mucosa by Submucosal Injection in the Porcine Model.- 55. Urinary Diversion in the Management of Chronic Perineal Skin Ulceration in Spinal Cord Injured Patients Following Sphincterotomy.- 56. The Artificial Urinary Bladder.- 57. Comparison of the Breaking Strength of Polyglactin Mesh in Urine, Serum, and Cell Culture Media.- 58. Growth of Cultured Human Urothelial Cells Into Stratified Urothelial Sheet Suitable for Autografts.- 59. Future Perspectives in Bladder Reconstruction.

    1 in stock

    £161.99

  • Breast Cancer

    National Academies Press Breast Cancer

    1 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    1 in stock

    £106.17

  • PatientCentered Cancer Treatment Planning Improving the Quality of Oncology Care Workshop Summary

    National Academies Press PatientCentered Cancer Treatment Planning Improving the Quality of Oncology Care Workshop Summary

    1 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    1 in stock

    £17.99

  • The Role of Clinical Studies for Pets with Naturally Occurring Tumors in Translational Cancer Research Workshop Summary

    National Academies Press The Role of Clinical Studies for Pets with Naturally Occurring Tumors in Translational Cancer Research Workshop Summary

    1 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    1 in stock

    £29.75

  • Oncologic Imaging A Multidisciplinary Approach

    Elsevier - Health Sciences Division Oncologic Imaging A Multidisciplinary Approach

    1 in stock

    Book SynopsisTable of Contents1 A Multidisciplinary Approach to Cancer: A Radiologist's View 2 A Multidisciplinary Approach to Cancer: A Surgeon's View 3 A Multidisciplinary Approach to Cancer: A Medical Oncologist's View 4 A Multidisciplinary Approach to Cancer: A Radiation Oncologist's View 5 Assessing Response to Therapy 6 Head and Neck Cancer 7 Lung Cancer 8 Primary Mediastinal Neoplasms 9 Pleural Tumors 10 Liver Cancer: Hepatocellular and Fibrolamellar Carcinoma 11 Cholangiocarcinoma 12 Pancreatic Ductal Adenocarcinoma 13 Cystic Pancreatic Lesions 14 Pancreatic Neuroendocrine Tumors 15 Esophageal Cancer 16 Gastric Carcinoma 17 Small Bowel Malignant Tumors 18 Colorectal Cancer 19 Renal Tumors 20 Urothelial Carcinoma (Bladder Cancer and Upper Tracts) 21 Testicular Germ Cell Tumors 22 Primary Adrenal Malignancy 23 Prostate Cancer 24 Primary Retroperitoneal Tumors 25 Tumors of the Uterine Corpus 26 Cervical Cancer 27 Ovarian Cancer 28 Breast Cancer 29 Myeloma and Leukemia 30 Hematologic Malignancy: The Lymphomas 31 Thoracic Metastatic Disease 32 Metastases Abdominal-Pelvic Organs 33 Peritoneal Cavity and Gastrointestinal Tract 34 Bone Metastases 35 Cancer of Unknown Primary 36 Imaging in Thyroid Cancer 37 Melanoma 38 Soft Tissue Sarcomas 39 Interventional Imaging in the Oncologic Patient 40 Complications in the Oncologic Patient: Chest 41 Complications in the Oncologic Patient: Abdomen and Pelvis 42 Pulmonary Embolic Disease and Cardiac Masses and Tumors 43 Protocols for Imaging Studies in the Oncologic Patient 44 Front Matter

    1 in stock

    £163.79

  • Biomarkers in Urology An Issue of Urologic Clinics

    Elsevier - Health Sciences Division Biomarkers in Urology An Issue of Urologic Clinics

    1 in stock

    Table of ContentsApproaches and Barriers to Biomarker Discovery: The Example of Biomarkers of Renal Scarring in Pediatric Urology Biomarkers in Urolithiasis Biomarkers in Urethral Stricture Disease and Benign Lower Urinary Tract Disease Pathophysiology and Clinical Biomarkers in Interstitial Cystitis Urine-Based Markers for Detection of Urothelial Cancer and for the Management of Non-Muscle-Invasive Bladder Cancer Biological Stratification of Invasive and Advanced Urothelial Carcinoma The Association Between the Urinary Microbiome and Bladder Cancer Combined Use of Magnetic Resonance Imaging and Biomarker Testing to Detect Clinically Significant Prostate Cancer Circulating Tumor Cells and Circulating Tumor DNA in Urologic Cancers Targeted Molecular Imaging as a Biomarker in Urologic Oncology Biomarkers in Testicular Cancer: Classic Tumor Markers and Beyond The Evolving Landscape of Viral, Immune, and Molecular Biomarkers in Penile Cancer Current and Future Biomarkers in the Management of Renal Cell Carcinoma

    1 in stock

    £77.39

  • Effective Group Therapies for Young Adults

    Taylor & Francis Ltd Effective Group Therapies for Young Adults

    1 in stock

    Book SynopsisOutlining the unique psychosocial and development issues faced by young adults affected by cancer, this text draws on qualitative data from two pilot studies conducted in the United States to illustrate how the needs of this often-overlooked population can be effectively met via group therapy in clinical settings. Drawing on 25 years of experience as a licensed clinical social worker supporting pediatric and young adult cancer patients and their families, Kurker focuses on the role of the clinician in structuring support group sessions. Chapters draw on patient perspectives to demonstrate effective application of interventions to help adolescents work through trauma associated with a diagnosis of cancer, treatment, recovery and the impacts on their development. Outcomes from these studies also include strategies for selecting support group participants, structuring group activities and securing funding. Effective Group Therapies for Young Adults Affected byTrade Review "Sarah Kurker has beautifully illustrated a very practical resource for clinicians interested in providing a group therapy experience for young adult populations who have been affected by cancer. Her passion for as well as her wealth of experience shines through in the descriptions of her work with this group of young people. […] Sarah provides a summary of the research on key developmental, emotional, and physical challenges faced by this population as they navigate a cancer diagnosis and therapy. She provides very practical, step-by-step guidance on developing, facilitating, and evaluating groups for young adults who are in the midst of treatment or struggling with post-treatment issues." -- Wendy Pelletier, Pediatric Oncology Social Worker, Alberta Children’s Hospital, Canada Table of Contents Preface Chapter Overviews 1. Understanding Developmental Issues for Young Adults with Cancer 2. Supporting Young Adults in a Closed Group Format: Insights from Practice at Massachusetts General Hospital 3. Supporting Young Adults in a Group Format: Insights from Practice with the Candlelighters’s Community 4. Pre and Post Evaluation Significance of Group Support Structures 5. Life Lessons from the Young Adults

    1 in stock

    £37.49

  • Breast Diseases

    Taylor & Francis Ltd Breast Diseases

    1 in stock

    Book SynopsisThis comprehensive textbook incoporates all aspects of breast disease, including basic science, benign breast diseases, malignant neoplasms, diagnostics, multidisciplinary therapeutic options, and molecular biology research. It focuses on information useful for trainees, medical students, and practicing breast surgeons and oncologists. The highlight of the book is to present the controversies and arrive at a consensus in an evidence-based narrative. It aims to be useful not only for daily practice but also to establish a firm knowledge platform for clinicians and research scientists by outlining the guidelines for the treatment plan.Key Features Has a global perspective and encourages implementation of the guidelines for management in daily practice Enriched with high-quality illustrations and flowcharts for easy understanding of trainees, fellows, and breast surgeons Covers the latest innovations and research in breast disease managementTable of ContentsCore area I Epidemiology 1. Epidemiology of Breast Cancer.Core area II Radiology 2.Breast imaging for the Surgeon.Core area III Physiology and Benign Conditions 3. Developmental anomalies of Breast. 4. Pathophysiology and Hormonal factors involved during pregnancy and lactation and its effects on lactogenesis. 5. Benign breast disease.Core area IV Etiology, Molecular basis, and screening 6. Etiopathogenesis, Risk Factors and Genomics in Breast Cancer. 7. Management of the high-risk Patient. 8. Breast Cancer Screening: A Need for Comparative Effectiveness Research. 9. Management of high-risk lesions and in situ cancers. 10. Staging of Breast Cancer.Core area V Management of breast cancer 11. The Management of Impalpable Breast Lesions.12. Paget’s disease of Breast. 13. Management of Early breast cancer. 14. Controversies and consensus in management of axilla. 15. Locally advanced breast cancer. 16. Special considerations in breast cancer management: Breast Cancer and fertility, Pregnancy associated breast cancer. 17. Male breast cancer. 18. Prognostication in breast cancer. 19. Management of metastatic breast cancer.Core area VI Operative surgery in breast cancer 20. Breast Conservation Therapy. 21. Principals in Oncoplastic Breast Surgery. 22. Principles of Breast Reconstruction. 23. Surgical Management of Breast Cancer Related Lymphoedema.Core area VII Adjuvant and neoadjuvant therapy 24. Radiation oncology: practice guidelines. 25. Chemotherapeutic interventions. 26. Molecular targets and immunotherapy.Core area VIII Miscellaneous 27. Special issues in breast tumours: Phylloides, Sarcoma. 28. Breast cancer in developing countries: issues and solutions. 29. Breast cancer Survivorship. 30. Recent Trials in Surgical Management of Breast cancer.

    1 in stock

    £64.99

  • Natures CancerFighting Foods Prevent and Reverse

    Penguin Books Ltd Natures CancerFighting Foods Prevent and Reverse

    1 in stock

    Book SynopsisBased on a solid foundation of the healing properties of good nutrition, this book empowers readers with the information they need to make the best choices and to gain control over their total health and well-being - physical, emotional, and spiritual. While addressing the specific needs of those with a diagnosis of cancer, Varona explores the key factors that science and experience have shown to influence the path of prevention and recovery. Grounded in documented research from leading medical institutions - along with studies of the world's healthiest populations - nutrition educator Verne Varona has developed a breakthrough nutritional and lifestyle programme for immunity building and cancer prevention and recovery. This book provides detailed diet and lifestyle modifications that will reinforce the body's immunity and reduce cell-damage to an absolute minimum. While the bulk of this book is devoted to physical nutrition, eating the right foods is not the whole picture. No matterTrade Review"If you have the inspiration, this book is an excellent, unbiased source of information that can help you on your healing journey." ---Bernie Siegel, M.D., author of Love, Medicine & Miracles and Prescriptions for Living "Simple, clear, effective techniques and explanations that can prevent cancer and alter its path." ---Michelle LeClaire O'Neill, Ph.D, R.N., director Mind/Body Center, author of Twelve Weeks to Fertility "Verne Varona clarifies many dietary myths while presenting a clear nutritional guideline for cancer-prevention strategies. This book presents powerful information that should be available to all." ---Jack Canfield, co-author, Chicken Soup for the Soul"Verne Varona offers invaluable information about how to consciously and positively transform our health. His writing and deep sense of caring make him an outstanding and unique individual in the field of preventive health care." ---Barbara De Angelis, Ph.D., author of Real Moments "Nature’s Cancer Fighting Foods, is a lifesaver. Not just for cancer candidates, but for anyone who wants to eat sanely in a world where convenience and efficiency has taken precedent over health. It’s filled with crucial information and is actually fun to read." ---Alan Arkin, actor "This unique, easy to digest volume offers a new depth of understanding to everyone—sick or healthy—on the power of foo, our most intimate relationship. Keep this straight-talking self healing primer close at hand." ---Organica Magazine "Nature’s Cancer-Fighting Foods is a much-needed resource for combating the growing cancer epidemic." ---Hyla Cass, M.D., author of St. John's Wort: Nature's Blues Buster"Nature’s Cancer-Fighting Foods is an excellent encyclopedic work for self-healing." ---William Dufty, author of Sugar Blues

    1 in stock

    £10.44

  • Chronic Myeloproliferative Disorders

    Taylor & Francis Ltd Chronic Myeloproliferative Disorders

    1 in stock

    Book SynopsisChronic Myeloproliferative DisordersTable of ContentsI. Bcr/Abl Positive Chronic Myeloproliferative Disorders. 1. Epidemiology and history. 2. Cytogenetics and molecular biology. 3. Risk stratification. 4. Clinical features. 5. Non-transplant treatment options. 6. Allogeneic stem cell transplantation. 7. Autologous stem cell transplantation. 8. Vaccines. 9. A therapeutic algorithm and concluding remarks. II. Bcr/Abl Negative Chronic Myeloproliferative Disorders. 10. Epidemiology and history. 11. Cytogenetics and molecular biology. 12. Risk stratification. 13. Clinical features. 14. Non-transplant treatment options. 15. Transplantation options. 16. A therapeutic algorithm and concluding remarks.

    1 in stock

    £131.68

  • Petz  Garrattys Immune Hemolytic Anemias

    Elsevier Health Sciences Petz Garrattys Immune Hemolytic Anemias

    1 in stock

    1 in stock

    £145.79

  • Where the Sun Dont Shine

    Bell Bottom Press Where the Sun Dont Shine

    1 in stock

    Book Synopsis

    1 in stock

    £9.78

  • Cancer Is Complicated

    Penguin Young Readers Cancer Is Complicated

    1 in stock

    1 in stock

    £22.09

  • Understanding Cancer A Patients Guide to

    Johns Hopkins University Press Understanding Cancer A Patients Guide to

    1 in stock

    Book SynopsisCompassionate, accessible, and informative, Understanding Cancer will increase the reader's knowledge of medical concepts and terms so the person with cancer, the family, and the health care team can work together efficiently-and effectively.Trade ReviewCancer patients who want to be fully informed participants in their own health care will find this a valuable handbook. Publishers Weekly Well written and informative. -- Susan Walker International Journal of Radiation Oncology Biology Physics 2007 This well written, up-to-date book is concise and easy to read and understand. Written in everyday language without being overly simplistic, the book provides clear explanations, examples, and practical advice that can serve as a framework for treatment decisions... 3 stars Doody's Review Service 2007Table of ContentsForeword by Edward C. Halperin, M.D.Foreword to the First Edition by Ellen L. StovallPrefaceIntroduction1. Diagnosis and Treatment: What You Can Expect2. Cancer: Where Does It Come From?3. Diagnostic Tests and Staging Studies: Gathering Information4. Making Decisions about Treatment: How Success Is Measured5. Weighing the Long-Term Risks and Benefits of Treatment6. Conventional Treatments: An Overview7. Molecular-Target Therapy8. Clincial Research Trials: What They're All About9. Clinical Case Studies: Four Patient StoriesAfterwordAppendixesA. Cancer Molecular BiologyB. Analyzing Cost-EffectivenessC. Performance Status Scoring SystemsD. Patient's ChecklistBibligraphyIndex

    1 in stock

    £36.45

  • Microcirculation in Cancer Metastasis

    CRC Press Microcirculation in Cancer Metastasis

    1 in stock

    Book SynopsisAlthough mechanisms involved in the spread of cancer have been the subject of a major research endeavor over the past decade, metastatic tumors still account for significant clinical morbidity and the failure of cancer treatment. Not only are the vascular pathways the most common route for the dissemination of cancer cells, but interactions between the cells and the circulation act as important rate-regulators for the metastatic process.This authoritative, multi-authored volume addresses the importance of microcirculation in cancer metastasis. The book begins with up-to-date reviews on the biology of endothelial cells and the structure and physiology of the normal and tumor microcirculations, and then emphasizes interactions between components of the microcirculation and cancer cells. Metastasis is discussed through chapters exploring the entry of cancer cells into the circulation, the biophysics and morphology of cancer cell traffic and arrest, interactions with host cellsTable of ContentsChanges in the Extracellular Matrix During Transformation and Differentiation (James Varani, Ph.D. and Subhas Chakrabarty, Ph.D.). Interactions of Tumor Cells with Basement Membranes (Victor Terranova, D.M.D., Ph.D.). Endothelial Cell Function and Metastasis (Michael R. Buchanan, Ph.D. and Maria Bertomeau, M.D.). Passage Across the Vascular Wall by Malignant Cells in Metastasis Formation (Peter De Bruyn, M.D.). Entry of Cancer Cells Into the Vasculature (Kurt Hellmann, M.D.). Interactions Between Circulating Cancer Cells and Host Leukocytes (Dorothy Glaves, Ph.D.). Platelets and Cancer Metastasis (Kenneth V. Honn, Ph.D., Irma M. Grossi, Ph.D., Josepf Timar, Ph.D., Hemi Chopra, Ph.D., and John Taylor, Ph.D.). The Thrombotic Consequences of Malignancy (Mohan Chelladurai, Ph.D.). The Biomechanics of Cancer Cell Traffic, Arrest, and Intravascular Destruction (Leonard Weiss, M.D.). The Role of Integrin Receptors in Tumor Cell Adhesion to the Microvasculature (Randall H. Kramer, Ph.D., Judy Ennenstein, Ph.D., Daniel M. Ramos, D.D.S., Mai P. Vu, B.Sc., and Yao Fen Cheng, M.Sc.). Interactions Between Cancer Cells and the Endothelium (Robert Auerbach, Ph.D.). Selective Involvement of a Specific Sinusoidal Domain in Hepatic Metastasis (Emilio Barberá-Guillem, M.D. and Fernando Vidal-Vanaclocha, M.D.). The Morphology of Cancer Cell Arrest and Extravasation (John Crissman, M.D., Robert Cerra, Ph.D., and Fuzlul Sarkar, Ph.D.). Fatty Acid Metabolism and Cancer Cell-Endothelial Cell Interactions (Michael R. Buchanan, Ph.D., Maria Bertomeau, M.D., and Thomas A. Haas, Ph.D.). The Influence of Endothelial Injury and Inflammatory Processes on Metastasis (F. William Orr, M.D.). The Role of Vascularization in Tumor Metastasis (Marsha Moses, Ph.D.). The Microcirculation of Tumors (Hans-Inge Peterson, M.D.).

    1 in stock

    £125.00

  • Lifeline The Case for Effective Cancer

    T.S.Aguilar Lifeline The Case for Effective Cancer

    1 in stock

    Book Synopsis

    1 in stock

    £18.75

  • Enough

    Cambridge University Press Enough

    5 in stock

    Book SynopsisA passionate call to action to eliminate needless deaths from cervical cancer, by combatting healthcare inequities women face. Dr Eckert weaves together survivors' stories with her own expert, evidenced-based information. By breaking down cultural and political barriers, we can work together to eliminate the world's most preventable cancer.Trade Review'Beautifully written, Enough is a searing call to arms, for too many women are dying of cervical cancer when we have the tools to save their lives. The unnecessary human cost of cervical cancer is a scandal, and one that Dr. Eckert is determined to fix.' Nicholas Kristof, Columnist, The New York Times and co-author of Half the Sky'Eckert presents an urgent and powerful call to action to save lives, based on her decades of practice and research around the world. Enough is an essential resource for anyone concerned with public health, women's rights, and addressing racial and national inequities in healthcare.' Anjli Parrin, Director, Global Human Rights Clinic, University of Chicago Law School'This is a beautifully written powerful tale of truth and hope, as Dr. Eckert combines her authoritative work with cervical cancer prevention alongside the inspiring voices of women from all over the world.' Princess Nono Simelela, Former WHO Assistant Director General for Strategic Priorities'Cervical cancer cannot be a disease of inequities anymore and the role of this book is crucial to always remember this. Thanks to the author for this essential piece of advocacy.' Nathalie Broutet, Nathalie Broutet, M.D., Ph.D., Lead of the cervical cancer elimination initiative (2005–2022), WHO Department of Sexual and Reproductive Health and Rights'A book to read, to gift, to pass on to friends and those who need to know, to USE to make change – Dr. Eckert deftly intertwines the barriers to achieving [cervical cancer elimination], the science and financial issues as well as cultural issues and the bewildering continuing disvaluing of women's rights and lives.' Joanna M. Cain, M.D., Professor (retired) University of Massachusetts and Co Chair, Cervical Cancer subcommittee International Federation of Gynecology and Obstetrics (FIGO)'Dr Eckert details moving and powerful stories of women battling cervical cancer. Many will bring you to tears, especially as Dr. Eckert educates us that nearly all of the cancers are preventable. In the end she gives us a hopeful roadmap to address health inequities and systems challenges that would allow us to end this deadly cancer.' Barbara Goff, M.D., Professor and Chair, Department of Obstetrics and Gynecology, UW Medicine, Surgeon-in-Chief, University of Washington Medical Center'Cervical cancer is a preventable disease. Enough is the book that should be put in the hands of anyone who has received a [cervical cancer] diagnosis or is supporting someone with a diagnosis.' Diana Rivington, Emeritus of the Canadian International Development Agency (CIDA)'As those with cervical cancer tell their stories, cervical cancer becomes real. This story could be your sister, your mother, your daughter, your aunt, your life partner. Cervical cancer strikes in Zambia, or in Canada, in Honduras, or Australia. In Enough these individuals, whose stories are wonderfully expressed, come to life.' Karen Nakawala, cervical cancer survivor, Founder of Teal Sisters, Zambia'I would strongly recommend this book to anyone seeking to learn more about cervical cancer, especially those developing health policies.' Aisha Jumaan, Founder and President of Yemen Relief and Reconstruction Foundation, Previous director of the HPV Vaccines: Evidence of Impact project'This book opened my eyes so wide and showed the whole world what cervical cancer is. All aspects, all successes, all failures.' Icó Tóth, President, Mallow Flower Foundation, Hungary'Intimate, and informative, Enough reminds us that the choice to end cervical cancer belongs to each of us. Now is the time to act.' Heather White, TogetHER for Health (www.togetherforhealth.org)'This book serves as a powerful resource to educate medical professionals and the public alike to take charge on self-care and work towards a cervical cancer-free world.' Shobha S. Krishnan, Founder and President, Global Initiative Against HPV and Cervical CancerTable of ContentsIntroduction: The calling; Part I. A Preventable Cancer: 1. The potent promise and the rotten reality; 2. The vision; 3. Must we ask what a woman is worth?; Part II. The Science Behind Cervical Cancer: 4. The dangerous clout of a sexually transmitted virus; 5. The power of prevention; 6. The toll of treatment; 7. Gasoline on the fire: when HIV meets HPV; Part III. The Prevention Problem: 8. The deadly link between inequality and cervical cancer; 9. Losing the life lottery because of where you are born; 10. Sex, lies, and logistics: obstacles to vaccination beyond the marketplace; 11. Putting out the fires: obstacles to screening; 12. 'Dying inside': obstacles to treatment-and the catastrophic consequences; 13. What money cannot buy; Part IV. Getting to Enough: 14. A sea change starts with a ripple; 15. Wanted: men to champion the movement; 16. Join the collective cry of 'enough!'.

    5 in stock

    £18.00

  • Flow Cytometry in Neoplastic Hematology

    Taylor & Francis Ltd Flow Cytometry in Neoplastic Hematology

    1 in stock

    Book SynopsisThis fourth edition presents an updated and expanded text and illustrations to reflect continued morphologic, immunophenotypic, and especially molecular advances in the field of neoplastic hematology, mostly due to the rapidly expanding application of next-generation sequencing. Those advances not only allow a more reliable diagnosis of the majority of tumors and identification of early changes such as monoclonal B-cell lymphocytosis or clonal hematopoiesis of indeterminate potential (CHIP), but also in many cases identify mutations or phenotypic changes in tumors that can be targeted by mutation-specific or antigen-specific drugs. This edition incorporates the updated WHO classification of hematopoietic tumors and new immunophenotypic and molecular markers to provide a thorough pathologic overview of hematologic neoplasms while focusing on flow cytometric features. Special emphasis has been put on hematological neoplasms with crucial clinical significance such as acute promyelocytic leukemia, other acute leukemias, and difficult areas in flow cytometry. Flow cytometric features in AML, MDS, CMML, CLL and measurable residual disease were significantly expanded. There are many new comparative tables, illustrations, and diagrams of algorithmic approaches.Table of ContentsPreface. Abbreviations. Introduction to Flow Cytometry. Flow Cytometry Analysis of Blood and Bone Marrow. Identification of Clonal B-Cell Population. Identification of Abnormal T-Cell Population. Identification of Myeloblasts. Identification of Lymphoblasts. Immunophenotypic Markers in Flow Cytometry. Morphologic-Flow Cytometric Correlation in Blood. Morphologic-Flow Cytometric Correlation in Bone Marrow. Morphologic-Flow Cytometric Correlation in Lymph Nodes. Molecular-Flow Cytometric Correlation. Phenotypic Classification of Mature B-Cell Neoplasms. Mature B-Cell Lymphoproliferations. Plasma Cell Neoplasms. Phenotypic Classification of Mature T/NK-Cell Lymphoproliferations. Mature T/NK-Cell Lymphoproliferative Disorders. B-Cell Acute Lymphoblastic Leukemia/Lymphoma. T-Cell Acute Lymphoblastic Leukemia/Lymphoma. Myelodysplastic Syndromes. Mixed Myelodysplastic-Myeloproliferative Neoplasms. Myeloproliferative Neoplasms. Acute Myeloid Leukemia, Not Otherwise Specified. Acute Myeloid Leukemia With Recurrent Genetic Abnormalities. Measurable (Minimal) Residual Disease in AML. Acute Leukemias of Ambiguous Lineage. Other Neoplasms and PNH. Index.

    1 in stock

    £150.00

  • Practical Guide for Imaging of Soft Tissue

    Taylor & Francis Ltd Practical Guide for Imaging of Soft Tissue

    1 in stock

    Book SynopsisSoft tissue tumours are extremely common although difficult to understand due to a large number of sub-types, leading to a significant increase in their imaging in the last decade. This highly illustrated practical book provides a simplified, systematic approach to imaging, reporting and diagnosing these tumours. It covers all the modalities with emphasis on ultrasound and MRI, along with the newer techniques in these modalities. This concise guide to soft tissue lesions, will help clinicians to quickly understand the spectrum of tumours and identify the appropriate imaging techniques to best serve their patients.Key Features: Provides guidance by international experts on various types of soft tissue tumours (benign, malignant and tumour mimics), their relevant imaging features to help suggest specific or differential diagnosis and when to biopsy and when to refer to specialist centres Proves to be an excellent resource for general and specialist radiologisTable of Contents Preface. Acknowledgements. About the editors. List of contributors. Approach to soft tissue lesions. Imaging modalities and techniques in soft tissue tumours. Lipomatous tumours. Fibroblastic, myofibroblastic and fibrohistiocytic tumours. Peripheral nerve tumours. Synovial pathologies. Muscle tumours. Vascular tumours. Tumours of uncertain origin. Other non-sarcomatous soft tissue tumours. Soft tissue tumour mimics. Biopsy of soft tissue tumours. Histopathology of soft tissue lesions. Imaging of post-treatment changes in soft tissue sarcomas. Index.

    1 in stock

    £59.99

  • Cancer Targeting Therapies

    CRC Press Cancer Targeting Therapies

    1 in stock

    Book SynopsisThis volume in the popular series, Drugs and the Pharmaceutical Sciences, begins with the history of cancer treatment, carcinogens, and molecular mechanisms involved in cancer pathogenesis. It incudes conventional and advanced cancer therapies ranging from oral and parenteral preparations to advanced fabricated systems such as nanoparticles, liposomes, antibodies, aptamers, poly(amidoamine) and photodynamic therapies. The preparation and mechanisms of molecular targeting of cancer are presented and the authors focus on a diverse audience including undergraduates and research students.Features Timely coverage of changes in process control technology for the phamaceutical industry, a dynamic area in terms of products and manufacturing processes Provides an update on the unique requirements of these industries and how they differ from others, for example the microelectronics or specialized chemicals industries Draws on the author's vast experience in the field of industrial hygiene and hazardous materials Presents a collection of unique situations in which industrial hygiene was implemented to resolve a variety of scenarios and did not interfere with quality issues Addresses current topics relating to industry evolution such as migration of therapies to higher potency, RiskMAP, new modalities in medicines and treatments, large molecule therapeutics and conjugates

    1 in stock

    £29.99

  • Intracranial Stereotactic Radiosurgery

    CRC Press Intracranial Stereotactic Radiosurgery

    1 in stock

    Book SynopsisThis fourth edition of Intracranial Stereotactic Radiosurgery builds upon the success of its previous editions to provide a comprehensive assessment of contemporary approaches and indications for intracranial stereotactic radiosurgery (SRS).Key topics include benign and malignant tumors, cerebrovascular abnormality, and functional disorders. In addition, two brand new chapters are introduced, focusing on the application of AI to SRS for intracranial lesions, and the consideration of large-scale brain networks. Authored by leading experts from across the world, this book offers a fundamental insight into the field of radiosurgery.Suitable for postgraduate students studying radiation therapy and medical physics, this text is a fundamental resource for all professionals and practitioners working in radiosurgery and radiation therapy.

    1 in stock

    £188.01

  • Urothelial Carcinoma

    Springer-Verlag New York Inc. Urothelial Carcinoma

    1 in stock

    Book SynopsisThis fully updated volume explores recently improved avenues to study urothelial carcinomas.Table of ContentsPart I: Molecular Characterization 1. Scoring Systems for Immunohistochemistry in Urothelial Carcinoma Mark-Sebastian Bösherz, Iryna V. Samarska, and Nadine Therese Gaisa 2. A Panel-Based Method for the Reproduction of Distinct Molecular Subtype Classifications of Muscle-Invasive Urothelial Bladder Cancer Csilla Olah and Tibor Szarvas 3. Analysis of Mutational Signatures Using the mutSignatures R Library Damiano Fantini and Joshua J. Meeks 4. A Drug Repurposing Pipeline Based on Bladder Cancer Integrated Proteotranscriptomics Signatures Marika Mokou, Shaman Narayanasamy, Rafael Stroggilos, Irina-Afrodita Balaur, Antonia Vlahou, Harald Mischak, and Maria Frantzi 5. Characterization of Native COMPASS Complex in Urothelial Carcinoma Cells by Size Exclusion Chromatography Christoph Peter, Wolfgang A. Schulz, and Patcharawalai Whongsiri Part II: Urothelial Carcinogenesis 6. Reconstructing Phylogenetic Relationship in Bladder Cancer: A Methodological Overview Lancelot Seillier and Martin Peifer 7. Using Sister Chromatid Exchange Assay to Detect Homologous Recombination Deficiency in Epigenetically Deregulated Urothelial Carcinoma Cells Theodoros Rampias and Apostolos Klinakis 8. Identification of STAG2 Mutant Bladder Cancers by Immunohistochemistry Youngrok Park, Alana Lelo, Brent Harris, Deborah L. Berry, Krysta Chaldekas, Jung-Sik Kim, and Todd Waldman Part III: Cellular and Animal Models 9. Genome-Wide CRISPR Screening for the Identification of Therapy-Resistance-Associated Genes in Urothelial Carcinoma Klaus Mantwill and Roman Nawroth 10. Tissue Slice Culture and Analysis of Tumor-Associated Hyaluronan in Urothelial Carcinoma William Donelan, Paul L. Crispen, and Sergei Kusmartsev Part IV: Biomarkers 11. NGS-Based Tumor-Informed Analysis of Circulating Tumor DNA Iver Nordentoft, Karin Birkenkamp-Demtröder, and Lars Dyrskjøt 12. Considering the Effects of Modern Point-of-Care Urine Biomarker Assays in Follow-Up of Patients with High-Risk Non-Muscle Invasive Bladder Cancer Thorsten H. Ecke, Natalya Benderska-Söder, Ekkehardt Bismarck, Bas W.G. van Rhijn, Tilman Todenhöfer, and Bernd J. Schmitz-Dräger 13. Simplex Droplet Digital PCR Assays for the Detection of TERT Promoter Mutations in Urine Samples for the Non-Invasive Diagnosis of Urothelial Cancer Maria Zvereva, Md Ismail Hosen, Nathalie Forey, Mahdi Sheikh, Caroline Kannengiesser, Ibrahima Ba, Arnaud Manel, Emmanuel Vian, and Florence Le Calvez-Kelm 14. Predictive Biomarkers of Response to Neoadjuvant Therapy in Muscle Invasive Bladder Cancer Jussi Nikkola and Peter Black 15. Assessment of PD-L1 Status in Urothelial Cancer Veronika Bahlinger, Arndt Hartmann, and Markus Eckstein Part V: Therapy Development 16. Epigenetic Priming and Development of New Combination Therapy Approaches Sarah Meneceur, Camilla M. Grunewald, Günter Niegisch, and Michèle. J. Hoffmann 17. Evaluation of FGFR Alteration Status in Urothelial Tumors Veronika Bahlinger, Markus Eckstein, Arndt Hartmann, and Robert Stöhr 18. Antibody-Drug-Conjugates (ADC): A Novel Treatment Option in Urothelial Carcinoma Günter Niegisch 19. Intravesical Infusion of Oncolytic Virus CG0070 in the Treatment of Bladder Cancer Paola Grandi, Andrea Darilek, Anay Moscu, Anu Pradhan, and Roger Li 20. Analysis of ICAM-1 Expression on Bladder Carcinoma Cell Lines and Infectivity and Oncolysis by Coxsackie Virus A21 Kate Relph, Mehreen Arif, Hardev Pandha, Nicola Annels, and Guy R. Simpson

    1 in stock

    £179.99

  • Pancreatic Cancer

    Johns Hopkins University Press Pancreatic Cancer

    1 in stock

    Book SynopsisThe authors hope that their honest yet hopeful perspective will help all people with cancer and those who care about them.Trade ReviewAn authoritative manual of instructions... This book is highly recommended. -- M. G. Paregian Brief (at just 171 pages) but powerful, this straightforward book is both sobering and inspiring. Hopkins Medicine No matter how experienced a professional might be in dealing with patients with pancreatic cancer, it is refreshing to hear from the patient's perspective, reading how they navigate through the system before they land in our clinic and receive our care. Overall, I would recommend this book to all health professionals who care for patients with pancreatic cancer (both novice and seasoned), as well as those who are adjusting to a diagnosis of pancreatic cancer. -- Raymond Chan Cancer Forum This book is excellent. It is positive and compassionate... It would make a useful contribution to a library. Macmillan Cancer Support This book is a valuable source of intimate details about Pancreatic Disease and related problems... Highly recommended for the practicing instructions and frank discussions of personal and family preparation along with the current treatments that are available. M. G. ParegianTable of ContentsPreface1. The Gathering Clouds2. What Is Pancreatic Cancer and What Are Its Symptoms?3. The Fight Begins4. The Initial Treatment5. The Prospect of Death6. Balancing Hope and Truth7. Family and Friends8. Managing the Symptoms of Advanced Cancer9. A New Approach to Living10. Next Steps11. What We've Learned from Our ExperienceAppendix: Supplemental InformationNotesIndex

    1 in stock

    £37.35

  • Radiosensitizers and Radiochemotherapy in the

    Taylor & Francis Inc Radiosensitizers and Radiochemotherapy in the

    1 in stock

    Book SynopsisRadiosensitizers and Radiochemotherapy in the Treatment of Cancer catalogs and describes the mechanism of action for entities characterized as radiosensitizers. Developments in the biological and physical sciences have introduced new radiosensitizers and defined novel targets for radiosensitization. As a result, a book about radiosensitization must now address a huge range of topics, covering everything from molecular oxygen and high Z elements to monoclonal antibodies and complex phytochemicals. At the molecular level, the understanding of the molecular consequences of DNA damage and the DNA damage response have informed the development of targeted radiosensitizers and shed light on the mode of action of radiochemotherapy protocols of known clinical efficacy. In this book the mechanisms of action at the molecular and cellular level are described for documented radiosensitizers including, where applicable, a brief history of their cTrade Review"This book is intended for both graduate students and seasoned researchers seeking a detailed review covering the therapeutic benefits of a combination of radiotherapy and drugs that alter the metabolism of cancer cells and their response to radiation. The summary at the end of each chapter targets the important points and directs the reader to the sections that are most relevant to him. Although preclinical studies are widely documented, the author took care to establish the links with clinical trials to appreciate the real impact of the various combinations of radio- and chemotherapy." -Benoit Paquette, Professor and Head of the Department of Nuclear Medicine and Radiobiology, University of Sherbrooke "This book is a great contribution to the field of radiation biology, examining the mechanisms of action, clinical uses, and targeting of radiation response modifiers, both radioprotectors and radiosensitizers. The depth and breadth of information covered in this text is exceptional and will be useful to oncologists, radiation oncologists, radiation biologists, medical physicists, and other radiation workers who seek to use radiation response modifiers in association with cancer therapy. This book will be useful in the clinical setting as well as in graduate school classrooms around the world." -Gayle E. Woloschak, Department of Radiation Oncology, Northwestern UniversityTable of ContentsRadiosensitization and Chemoradiation. Radiosensitization by Oxygen and Nitric Oxide. Radioenhancement by Targeting Cellular Redox Pathways and/or by Incorporation of High-Z Materials into the Target. Radiosensitization by Halogenated Pyrimidines. Radiosensitization by Antimetabolites. Radiosensitization by Platinum Drugs and Alkylating Agents. Topoisomerase Inhibitors and Microtubule-Targeting Agents. Targeting the DNA Damage Response: ATM, p53, Checkpoints, and the Proteasome. Radiosensitization by Inhibition of DNA Repair. Targeting Growth Factor Receptors for Radiosensitization. Targeting Signaling Molecules for Radiosensitization. Radiosensitization by Targeting the Tumor Microenvironment. Phytochemicals: Chemopreventive, Radiosensitizing, Radioprotective. Delivery Methods for Radioenhancing Drugs.

    1 in stock

    £175.00

  • Hormonal Carcinogenesis II

    Springer-Verlag New York Inc. Hormonal Carcinogenesis II

    1 in stock

    Book SynopsisFor those of us who have labored in the field of hormonal carcinogenesis, it has been most gratifying to see its rapid growth and increasing relevance in recent years. Although many factors and forces have contributed to this phenomenon, a few appear particularly significant. Perhaps foremost is the realization that two of the most prevalent cancers which afflict women and men; that is, breast and prostate, have essential hormonal component(s) to their etiologies. This should not surprise us since the high frequency of these cancers in human populations has to date not been attributed to any exogenous physical, environmental, or dietary factor(s). A similar argument may be applied to other less prevalent but equally important cancers including ovarian, endometrial, testicular, cervico vaginal, pituitary, thyroid, and sex hormone-associated hepatic neoplasms. The Office of ResearcTable of ContentsIntroductions.- Introductory Remarks.- Opening Address Important Questions in Women’s Health Research: Determining the Influence of Hormones on Health.- Symposium Presentations Mammary Carcinogenesis: A Unifying Hypothesis.- Regulation of Cytochrome P-450 and Carcinogenesis: Peroxisome Proliferator-Activated Receptor and Dioxin Receptor.- State Of The Art Lectures.- 1 Cell Cycle and Cell Proliferation.- 2 Role of a Cell Cycle Regulator in Hereditary and Sporadic Cancers.- 3 Molecular Cytogenetics of Solid Tumor Progression.- 4 Nucleocytoplasmic Shuttling of Estrogen Receptors Is Blocked by “Pure Antiestrogens”.- I. Epidemiology: Hormonal Cancers.- Causality in Hormone Associated Human Cancers.- 5 Breast Cancer Incidence in Women Exposed to Estrogen and Estrogen-Progestin Replacement Therapy.- 6 Breast Cancer Trends in Women in Sweden, the UK, and the USA in Relation to Their Past Use of Oral Contraceptives.- 7 Gene Expression in Familial Breast Cancer: A Genetic-Epidemiology Study of Premenopausal, Bilateral Breast Cancer.- 2. Breast/Mammary Gland.- The Importance of Human Breast Development in Mammary Carcinogenesis.- 8 Breast Susceptibility to Carcinogenesis.- 9 Hormones, Growth Factors and Gene Expression in Preneoplasias of the Mouse Mammary Gland.- 10 Pathogenesis of Ductal and Lobular Progestin-Induced Mammary Carcinomas in BALB/c Mice.- 3. Endometrium/Uterus.- 11 Is the hsp90 Connection Between Steroid Receptors and Immunosuppressant Binding Immunophilins Involved in the Control of Gene Transcription and Cell Growth?.- 12 Expression and Regulation of 17?-Hydroxysteroid Dehydrogenase Type 1 in Steroidogenic Cells and Estrogen Target Tissues.- Growth Factors in Endometrial Cancer.- 4. Kidney.- 13 Introduction Estrogens and Genitourinary Cancers of Syrian Hamsters.- 14 Interstitial Cell Origin of Estrogen-Induced Kidney Tumors in the Syrian Golden Hamster.- 15 Effects of Estrogens on Microtubule Assembly: Significance for Aneuploidy.- 16 Estrogen Carcinogenesis: A Sequential, Epi-Genotoxic, Multi-Stage Process.- 5. Liver.- Role of Estrogens in Liver Carcinogenesis.- 17 Hormonal Regulation of Hepatic Cell Proliferation and Apoptosis: Implications for Carcinogenesis.- 18 Mechanisms of Tamoxifen-Induced Genotoxicity and Carcinogenicity.- 19 Regulation of Growth-Associated Nuclear Transcription Factors During Growth Hormone-Regulated, Sex Differentiated Rat Liver Carcinogenesis.- 6. Prostate.- 20 Isolation of Differentially Expressed cDNAs from Prostate Cancer Cell Lines Using Differential Display PCR: Identification of an Androgen-Regulated Gene.- 21 Progression of LNCaP Human Prostate Carcinoma Cells: Androgen Receptor Activity and c-myc Gene.- 22 Regulation of Prostatic Growth and Gene Expression: Role of Stroma.- Concluding Remarks.- 23 Sex Hormones and Neoplastic Transformation.- CLINICAL FORUM: Risk and Benefits of Hormone Replacement Therapy and Oral Contraceptive Use.- Therapeutic Implications of Hormone Replacement Therapy and Oral Contraceptives.- 24 Postmenopausal Estrogen-Progestin Therapy in Relation to Cancers of the Endometrium and Breast.- 25 The Use of Hormone Replacement Therapy in Women Previously Treated for Breast Cancer.- 26 Cardioprotection by Hormone Replacement Therapy.- 27 Risk and Benefits of Oral Contraceptives.- 28 Oral Contraceptives and the Risk of Breast and Cervical Cancer.- Communications Session I. Epidemiology, Human Studies.- Some Aspects of Breast Cancer Epidemiology.- Risk of Breast Cancer Associated with Induced Abortion.- Family History of Breast Cancer as a Modifier of Other Risk Factors.- Oral Contraceptive Use and Reproductive Risk Factors for Breast Cancer: A Comparison of Results among Black and White Women.- Patterns of Cancer Mortality in Women Who Had Used Sex Steroid Hormones under Age 60.- Progestogen Use and Risk of Breast Cancer.- Five-Year Survival of Women with Breast Cancer According to Prior Use of Oral Contraceptives.- Plasma Prolactin and IGF-1 Levels in Young, Healthy, Nulliparous Women in Relation to Low Dose Oral Contraceptive Use.- Effect of a Low-Fat Diet on Estrogen and Bile Acid Metabolism in Normal Human Subjects.- Expression of GST? in Breast Cancer and its Relationship with the Expression of Estrogen Receptor and Progesterone Receptor.- p53 and Neu (c-erbB-2) Overexpression in Relation to Risk Factors for Breast Cancer.- Cost Effectiveness of Hormone Replacement Therapy in French Postmenopausal Women.- Tamoxifen Treatment Does Not Induce Endometrial Hyperplasia in Postmenopausal Women.- Uterine Myomas: A Model to Study Hormonal Regulation of Growth Related Genes.- Transforming Growth Factor ?1 Facilitates Cell Proliferation and Invasion in MAT-LyLu Prostatic Cancer Cells.- Quantitative Effects of Antiandrogen Therapy on High-Grade Prostatic Intraepithelial Neoplasia in Radical Prostatectomy Specimens.- Alterations in Circulating Levels of Androgens and PSA During Treatment with Finasteride in Men at High Risk for Prostate Cancer.- Session II. Cell & Molecular Biology, Metabolism.- Effect of Estradiol on MCF-7 Human Breast Cancer Cells: Ultrastructural Studies.- Estradiol and Tamoxifen Induce TGF-?l Gene Expression in Cultured Normal Human Breast Stromal Cells.- Estrogen and Anti-Estrogen Regulation of Amplified erbB2 Gene Expression in Human Breast Cancer Cells.- Evaluation of Conformational Changes in hER-HBD by Pharmacological Dissection of Hormone Dissociation Rates in a Homogeneous Hormone-Binding Assay.- Estradiol Promotion of Size and Number of Hepatic Enzyme-Altered Foci in Rats in the Absence of Cell Proliferation.- Expression of Liver-Enriched Transcription Factors During Progression in the Resistant-Hepatocyte Model.- Nuclear Protein Binding to the AP-1 and CRE Sites During Sex-Differentiated Promotion of Rat Liver Carcinogenesis.- Induction of Endometrial Cancer by Tamoxifen in the Rat.- Mechanisms of Anti-Estrogen and Retinoid Inhibition of Breast Cancer Cell Proliferation.- Bisphenol-A Disturbs Microtubule Assembly and Induces Micronuclei In Vitro.- Natural Estrogens Induce Modulation of Microtubules in Chinese Hamster V79 Cells in Culture.- Induction of Micronucleation, Spindle Disturbances, and Mitotic Arrest in Human Chorionic Villi Cells by 17?-Estradiol, Diethylstilbestrol, and Coumestrol.- Increased Nuclear IGF-I Receptor Level, Coupled with Attenuation in DNA Repair, Plays an Important Role in Estrogen-Induced Carcinogenesis.- Pattern of Reproductive Aging in Female Rats Can Affect Mammary Tumor Incidence.- Antiproliferative Activity of Luteolin, a Naturally-Occurring Edible Plant Flavone, Against Estrone-Induced Cell Proliferation in the Mammary Gland of Noble Rats.- Sex Hormone-Induced Prostatic Carcinogenesis in Noble Rats Involves Genetic Damage and Cell Proliferation.- Catechol Estrogen Analogs as Probes of Estrogen Carcinogenesis.- In-Vitro Metabolites of Coumestrol.

    1 in stock

    £40.49

  • Management of Soft Tissue Sarcoma

    Springer-Verlag New York Inc. Management of Soft Tissue Sarcoma

    1 in stock

    Book SynopsisManagement of Soft Tissue Sarcoma addresses the diagnosis and best current management of adult soft tissue sarcomas. Both clinical and molecular diagnoses are addressed, and tumor histopathology is employed as the basis of treatment recommendations including surgery, radiation therapy, systemic therapy and novel therapeutics.Trade Review“This is an excellent monograph of the Diagnosis, Pathology, Imaging, Treatment, and Surgical outcomes of sarcomas and related tumors of the soft tissue variety. … This is a very good book for oropedic surgeons, patologists, students, and clinicians with an interest in the diagnosis and treatment of high and low grade liposarcomas, leomyosarcomas, benign type lesions, and other kind of subcutaneous tumors with distant lung, brain, and liver metastases.” (Joseph J. Grenier, Amazon.com, October, 2015)“This is an impressive book. Written by a surgeon, a pathologist and an oncologist, the book draws heavily on the Memorial Sloan-Kettering Cancer Center soft tissue sarcoma (STS) database. … it is a book that should be in the library of any sarcoma unit and will appeal to the sub-specialist in Orthopaedic Oncology.” (Robert U. Ashford, European Journal of Orthopaedic Surgery & Traumatology, Vol. 24, 2014)“The book is laid out in 27 chapters, with an impressive inclusion of a wide array of sarcoma histology. One of the real strengths of the book is the quality and number of images, figures, tables, and graphs. … The overall outline of the text is well done. … This book is a unique and important addition to the sarcoma literature. … this edtion should find itself on every medical oncologist’s bookshelf … .” (Larry C. Daugherty and Sanjay P. Bagaria, Journal of Radiation Oncology, Vol. 3, 2014)Table of ContentsPrefaceIntroduction 1. General Description2. Natural History – Importance of Size, Site, Histopathology3. General Statement as to Efficacy of Surgery / Chemotherapy / Radiation Therapy Part I. Management by Histopathology - Introduction4. Gastrointestinal Stromal Tumor (GIST)5. Liposarcoma 6. Leiomyosarcoma 7. Undifferentiated Pleomorphic Sarcoma (UPS) (Malignant Fibrous Histiocytoma - MFH) / Myxofibrosarcoma 8. Synovial Sarcoma 9. Malignant Peripheral Nerve Sheath Tumor (MPNST) / Triton Tumor10. Desmoid Tumor / Deep-Seated Fibromatosis (Desmoid-type Fibromatosis)11. Solitary Fibrous Tumor / Hemangiopericytoma12. Fibrosarcoma and its Variants13. Vascular Sarcomas14. Epithelioid Sarcoma15. Sarcomas more Common in Children 16. Radiation Induced Sarcoma17. Alveolar Soft Part Sarcoma 18. Clear Cell Sarcoma / Melanoma of Soft Parts 19. Desmoplastic Small Round Cell Tumor 20. Extraskeletal Myxoid Chondrosarcoma 21. Other Uterine Sarcomas22. Extraskeletal Osteogenic Sarcoma23. Sustentacular Tumors of Lymph Tissue24. Uncommon / Unique Sites Part II. Benign and Less Aggressive Lesions - Introduction25. Mostly Benign / Rarely Metastasizing26. Benign Tumors27. Reactive Lesions10. Desmoid Tumor / Deep-Seated Fibromatosis (Desmoid-type Fibromatosis)11. Solitary Fibrous Tumor / Hemangiopericytoma12. Fibrosarcoma and its Variants13. Vascular Sarcomas14. Epithelioid Sarcoma15. Sarcomas more Common in Children 16. Radiation Induced Sarcoma17. Alveolar Soft Part Sarcoma 18. Clear Cell Sarcoma / Melanoma of Soft Parts 19. Desmoplastic Small Round Cell Tumor 20. Extraskeletal Myxoid Chondrosarcoma 21. Other Uterine Sarcomas22. Extraskeletal Osteogenic Sarcoma23. Sustentacular Tumors of Lymph Tissue24. Uncommon / Unique Sites Part II. Benign and Less Aggressive Lesions - Introduction25. Mostly Benign / Rarely Metastasizing26. Benign Tumors27. Reactive Lesions2. Natural History – Importance of Size, Site, Histopathology3. General Statement as to Efficacy of Surgery / Chemotherapy / Radiation Therapy Part I. Management by Histopathology - Introduction4. Gastrointestinal Stromal Tumor (GIST)5. Liposarcoma 6. Leiomyosarcoma 7. Undifferentiated Pleomorphic Sarcoma (UPS) (Malignant Fibrous Histiocytoma - MFH) / Myxofibrosarcoma 8. Synovial Sarcoma 9. Malignant Peripheral Nerve Sheath Tumor (MPNST) / Triton Tumor10. Desmoid Tumor / Deep-Seated Fibromatosis (Desmoid-type Fibromatosis)11. Solitary Fibrous Tumor / Hemangiopericytoma12. Fibrosarcoma and its Variants13. Vascular Sarcomas14. Epithelioid Sarcoma15. Sarcomas more Common in Children 16. Radiation Induced Sarcoma17. Alveolar Soft Part Sarcoma 18. Clear Cell Sarcoma / Melanoma of Soft Parts 19. Desmoplastic Small Round Cell Tumor 20. Extraskeletal Myxoid Chondrosarcoma 21. Other Uterine Sarcomas22. Extraskeletal Osteogenic Sarcoma23. Sustentacular Tumors of Lymph Tissue24. Uncommon / Unique Sites Part II. Benign and Less Aggressive Lesions - Introduction25. Mostly Benign / Rarely Metastasizing26. Benign Tumors27. Reactive Lesions10. Desmoid Tumor / Deep-Seated Fibromatosis (Desmoid-type Fibromatosis)11. Solitary Fibrous Tumor / Hemangiopericytoma12. Fibrosarcoma and its Variants13. Vascular Sarcomas14. Epithelioid Sarcoma15. Sarcomas more Common in Children 16. Radiation Induced Sarcoma17. Alveolar Soft Part Sarcoma 18. Clear Cell Sarcoma / Melanoma of Soft Parts 19. Desmoplastic Small Round Cell Tumor 20. Extraskeletal Myxoid Chondrosarcoma 21. Other Uterine Sarcomas22. Extraskeletal Osteogenic Sarcoma23. Sustentacular Tumors of Lymph Tissue24. Uncommon / Unique Sites Part II. Benign and Less Aggressive Lesions - Introduction25. Mostly Benign / Rarely Metastasizing26. Benign Tumors27. Reactive Lesions

    1 in stock

    £134.99

  • Papillomaviruses in Human Cancer

    Springer-Verlag New York Inc. Papillomaviruses in Human Cancer

    Out of stock

    Book Synopsis1. Human Papillomaviruses and Cancer: A Retrospective.- 2. Regulation of E6 and E7 Oncogene Transcription.- 3. E6 Protein.- 4. E7 Protein.- 5. Immunological Aspects of the E6 and E7 Oncogenes: Tools for Diagnosis and Therapeutic Intervention.Table of Contents1. Human Papillomaviruses and Cancer: A Retrospective.- 2. Regulation of E6 and E7 Oncogene Transcription.- 3. E6 Protein.- 4. E7 Protein.- 5. Immunological Aspects of the E6 and E7 Oncogenes: Tools for Diagnosis and Therapeutic Intervention.

    Out of stock

    £999.99

  • Cancer Biomarkers

    Taylor & Francis Inc Cancer Biomarkers

    1 in stock

    Book SynopsisThis unique synthesis of chapters from top experts in their fields, targets the very important and upcoming area of cancer biomarkers and the need for better and more rigorous design and clinical trial. The book covers several aspects of cancer molecular markers from innovation, screening, controversies and future directions. The primary target audience for the book includes PhD and MD students, researchers, biologists, medical doctors and professionals who are interested in mechanistic studies on cancer diagnosis and translational benefits from personalized cancer treatment using the new era of biomarkers.Table of ContentsImproving Research on Biomarkers for Early Detection and Screening of Cancers. Biomarkers of Oxidative Stress in Carcinogenesis. ß-Catenin: a Novel Biomarker and Therapeutic Target in Liver Cancer. Urine Biomarkers for Prostate Cancer Detection. Ectodomain Shedding as a Mechanism to Generate Cancer Biomarkers (Ectomarkers). The BRCT Signaling ‘landscape’: Emerging Concepts and Implications in Tumorigenesis and Cancer Diagnostics. Cellular Senescence and Cancer Development: Antagonistic and Synergistic Relations. Micro-RNAs: From Regulators of Gene Expression to Cancer Biomarkers. Targeting PARP-1 in Breast Cancer: The Paradigm of a DNA Repair-based Therapeutic Strategy. Statins in Prostate Cancer: Prevention and Treatment. Mechanistic Aspects of Oxidative Stress Involvement in Human Environmental and Occupational Carcinogenesis.

    1 in stock

    £140.00

  • Peptide-Based Cancer Vaccines

    Taylor & Francis Ltd Peptide-Based Cancer Vaccines

    1 in stock

    Book SynopsisThe field of peptide based cancer vaccines has evolved tremendously in the last decade of this century. The exploration on how to apply the peptide knowledge for vaccination purposes began when it was demonstrated that these peptides after being mixed into adjuvants actually induced T cell responses that could prevent virus infections and tumor growth in experimental animal models. The results of animal models are currently translated into clinical applications with all their associated difficulties and heterogeneity. Initial promising data do appear, warranting further research in this area. This book pays tribute to key researchers in the field.Table of Contents1. Identification and Selection of T-Cell Epitopes Derived from Tumor-Associated Antigens for the Development of Immunotherapy for Cancer 2. Mutant Oncogene and Tumor Suppressor Gene Products and Fusion Proteins Created by Chromosomal Translocations as Targets for Cancer Vaccines 3. p53: A Target for T-Cell Mediated Immunotherapy 4. Critical Dependence of the Peptide Delivery Method on the Efficacy of Epitope Focused Immunotherapy 5. Cancer Peptide Vaccines in Clinical Trials 6. Carcinoembryonic Antigen (CEA) Peptides and Vaccines for Carcinoma 7. Studies of M UCl Peptides 8. Cytotoxic T Cell Epitopes and Tissue Distribution of the HER-2/neu Proto-Oncogene: Implications for Vaccine Development 9. Clinical Trials of HER-2/neu Peptide-Based Vaccines 10. Peptides in Prostate Cancer 11. Peptides in Cervical Cancer 12. Peptide Vaccines for the Treatment of Melanoma 13. GplOO and G250: Towards Specific Immunotherapy Employing Dendritic Cells in Melanoma and Renal Cell Carcinoma 14. Melanoma Peptide Clinical Trial

    1 in stock

    £89.99

  • Nova Science Publishers Inc Oral Cancer Research Advances

    1 in stock

    Book SynopsisOral cancer is any cancerous tissue growth located in the mouth. It may arise as a primary lesion originating in any of the oral tissues, by metastasis from a distant site of origin, or by extension from a neighbouring anatomic structure, such as the nasal cavity or the maxillary sinus. Oral cancers may originate in any of the tissues of the mouth, and may be of varied histologic types: teratoma, adenocarcinoma derived from a major or minor salivary gland, lymphoma from tonsillar or other lymphoid tissue, or melanoma from the pigment producing cells of the oral mucosa. Far and away the most common oral cancer is squamous cell carcinoma, originating in the tissues that line the mouth and lips. Oral or mouth cancer most commonly involves the tissue of the lips or the tongue. It may also occur on the floor of the mouth, cheek lining, gingiva (gums), or palate (roof of the mouth). Most oral cancers look very similar under the microscope and are called squamous cell carcinoma. These are malignant and tend to spread rapidly. This new book presents important research from around the world.

    1 in stock

    £179.99

  • Nova Science Publishers Inc Progress in Cancer Prevention

    1 in stock

    Book SynopsisThis book presents research on advances in genetics, molecular medicine, biotechnologies, and behavioural sciences that have an impact on primary, secondary and tertiary cancer prevention. It includes research on: Basic mechanisms of neoplastic diseases leading to the identification of molecular pathways that can be employed as targets for cancer prevention; Descriptive, analytical, and molecular epidemiology with emphasis on developing biomarkers of cancer risk assessment and response to cancer prevention; Laboratory and clinical procedures for prognostic evaluation of malignant tumour transformation, progression and response to treatment with cancer preventive agents; Discoveries of natural substances and synthetic agents that have promising cancer preventive potential and elucidating their mechanistic action; Development and assessment of cancer preventive approaches that have potential for being translated into the clinic; Cancer prevention pre-clinical studies and clinical trials; Patient management and education, management of curable lesions, education and lifestyle modification and the role of behavioural factors in cancer aetiology and prevention.

    1 in stock

    £76.49

  • Nova Science Publishers Inc Gut Stem Cells: Multipotent, Clonogenic & the

    1 in stock

    Book Synopsis

    1 in stock

    £47.69

  • Nova Science Publishers Inc Human Papillomavirus (HPV) Involvement in

    1 in stock

    Book SynopsisEsophageal squamous cell carcinoma (SCC) has a peculiar geographical distribution, with up to 500-fold variations in incidence between the low- and high-risk regions. The first reports suggesting HPV involvement in both benign and malignant squamous cell tumours of the oesophagus date back to 1982. The rapidly increasing literature on this subject is summarised in this book. Screening studies in high-incidence areas of China using balloon cytology sampling report high prevalence of HPV DNA among asymptomatic subjects, followed by HPV DNA detection in hyperplastic and dysplastic epithelia adjacent to SCC. There are close human parallels to both SCP and SCC in the cattle, linked with BPV4 and alimentary carcinogens (bracken fern). In vitro experiments on HPV-positive cancer cell lines implicate similar molecular mechanisms as involved e.g. in HPV-associated genital carcinogenesis. Taken together, these data suggest that the (multifactorial) etiology of oesophageal cancer differs between the low- and high-incidence geographical areas. Oncogenic HPV types seem to play an important causal role only in the high-incidence regions.

    1 in stock

    £52.69

  • Yoga for Cancer: A Guide to Managing Side

    Inner Traditions Bear and Company Yoga for Cancer: A Guide to Managing Side

    Out of stock

    Book SynopsisFor those faced with a cancer diagnosis and the journey of doctor-led surgery and treatments, yoga offers a way to regain control of your body and take an active part in your recovery and long-term health. In this easy-to-follow illustrated guide, yoga teacher and cancer survivor Tari Prinster presents 53 carefully selected yoga poses and sequences, adaptable for all levels of ability, which use movement and breathing to address specific conditions and cancer challenges. Sharing her own story as well as those of cancer survivors and yoga teachers with whom she has worked, Prinster explores how yoga can be used to manage treatment side effects, strengthen the immune system, rebuild bone density, avoid and manage lymphedema, decrease anxiety, detoxify the body, reduce pain, and help the body repair damage caused by the cancer and conventional treatments. She reveals the research that supports the physical and psychological benefits of yoga as an aid to recovery and in reducing the risk of recurrence. Explaining how yoga must be tailored to each survivor, Prinster gives you the tools to create a safe home yoga practice, one that addresses your abilities, energy level, and overall health goals. Through personal stories, well-illustrated poses, and sample practices for beginners as well as experienced yoga practitioners, Prinster empowers survivors to create their own wellness plan in order to regain their independence and their physical and emotional well-being.Trade Review“Prinster, a breast cancer survivor and certified yoga teacher, presents an innovative plan to help readers diagnosed with cancer reap the benefits of yoga practice, from diagnosis through recovery. Admitting she was initially skeptical of yoga’s “healing powers,” Prinster takes readers through the scientific research, concluding that yoga can function as the “organ muscle” of the lymphatic system: helping with lymphatic drainage, venous return, bone building, relaxation, and immune function. Prinster also persuasively demonstrates how yoga can cleanse and strengthen the body, increase range of motion and flexibility, strengthen the spine, alleviate weight gain, and help patients deal with pain, fear, and anxiety. To meet the particular needs of cancer patients, the book presents 53 different poses, appropriate for different diagnoses or stages of treatment. Although Prinster notes the advantages of taking a group yoga class, this text will help readers build their own home practice (particularly useful for those who can’t locate a survivor class or would like to supplement one). In clear, compassionate language, Prinster explains her methodology and eloquently argues for yoga as a “prescription for reclaiming life and as a wellness plan for moving on to long-term health.” * Publishers Weekly, November 2014 *“A ‘must read’ for those contemplating yoga as a means to take charge of their lives after a diagnosis of cancer.” * JULIE A. ROSENBERG, M.D., RYT, pediatric oncologist and yoga instructor *“Yoga for Cancer is a look into Tari’s simple yet groundbreaking work with survivors. Her practical guide helps cancer survivors create a safe and inspiring home yoga practice. Tari’s gentle approach is complemented perfectly by her easy-to-follow guidance, making Yoga for Cancer an instrumental aspect of healing, surviving, and thriving after treatment.” * Elena Brower, coauthor of Art of Attention *“As a general oncologist, I wholeheartedly support Yoga for Cancer. Tari has successfully blended the ancient art of yoga with the contemporary art of oncology in a beautifully mindful but scientifically based manner.” * Julie J. Olin, M.D., Medical Oncology, Fletcher Allen Health Care, Vermont *“Yoga for Cancer is a yoga prescription for those touched by cancer. Tari offers support born of experience and tough love liberally sprinkled with compassion. As a writer and yoga teacher, I can say this book makes an important contribution to our collective knowledge of the healing powers of yoga.” * Linda Sparrowe, author of Yoga--A Yoga Journal Book *“Yoga for Cancer is a must read for all those living with cancer, providing the essential yoga tools with which you can construct your own wellness plan. If you are living with cancer and have tried yoga before or need an invitation to start, please read this book.” * Kate McIntyre Clere, filmmaker for Yogawoman *“Yoga for Cancer is a wonderful read and full of essential information for those living with breast cancer.” * Linda and Bob Carey, founders of The Tutu Project *“Tari’s empathy and knowledge of how the body works is a tremendous benefit to all who read Yoga for Cancer.” * Mio Fredland, M.D., psychiatrist, New York Presbyterian University Hospital *“A wonderful aid for beginners like me.” * Susan Gubar, writer of the Living with Cancer blog for the New York Times *“Tari’s passion to assist cancer survivors is outstanding. Her practice is easy to follow and helps us get over the past and move more powerfully in the future. She provides mind and body empowerment.” * Donna Wilson, RN, MSN, RRT, Memorial Sloan Kettering Cancer Center *“Tari Prinster was my Yoda-in-a-tank-top. I began taking her yoga classes simply to get back the range of motion in my arm and chest muscles, but her class taught me much more. I left stronger, inside and out. She expresses the lessons of her classes now in this book, and I’m thrilled she’ll get to touch so many more people.” * Shelley Lewis, cancer survivor and author of Five Lessons I Didn’t Learn from Breast Cancer *“Yoga for Cancer is a fact-based guide to healing. Tari explains in clear language what to do and why to unlock the healing potential of yoga.” * Stephanie M. Shorter, Ph.D., RYT, neuroscientist and founder of Mind-Body Collective *“While I was going through cancer treatments a few years ago, Tari’s classes really helped me focus on something else besides being sick. The techniques and wisdom in Yoga for Cancer are almost as good as having Tari right there with you.” * Jake Burton, founder and chairman of Burton Snowboards *“This book is a terrific guide for survivors to do a daily practice. Its goal is to make this method of yoga for cancer a beacon for every survivor in the form of a book. Tari did a wonderful job creating this step-by-step method, and survivors everywhere will benefit.” * Paulette Sherman, Psy.D., psychologist and author of The Cancer Path *“As a cancer survivor myself, I found Tari’s information on how to detoxify our body to be invaluable to my recovery. Yoga for Cancer is a useful tool for helping cancer survivors to reclaim their lives.” * Kathleen McBeth, clinical psychologist at the Cancer Patient Support Program *"An important addition to the growing collection of helpful resources for cancer survivors and yoga teachers is cancer survivor and yoga teacher Tari Prinster's recently released book, Yoga for Cancer: A Guide to Managing Side Effects, Boosting Immunity, and Improving Recovery for Cancer Survivors." * Baxter Bell, M.D., RYT *“Yoga for Cancer aids the recovering cancer patient and survivor with experience, warmth, and good sense.” * Loren M. Fishman, M.D., Manhattan Physical Medicine and Rehabilitation *“This is straight talk from someone who knows. In Yoga for Cancer, Ms. Prinster effectively demonstrates why and how to use yoga to cope with cancer and cancer treatments, to lessen treatment side effects, and to enrich patients’ lives as they regain and maintain their health.Yoga for Cancer sets out to help people live longer, healthier and happier lives. Writing it is a loving act of kindness by Ms. Prinster. This book is highly recommended for cancer patients and survivors, caregivers, and yoga instructors.” * New York Journal of Books, Birgit Patty, December 2014 *“Tari Prinster’s Yoga for Cancer is written as a guide for cancer patients and survivors, but the book is a wonderful introduction to the healing powers of yoga for anyone. …A road map for creating a home yoga practice to support physical and emotional well-being.” * Her Magazine, January 2015 *“Prinster’s text hits the mark. A deep knowledge of cancer’s effects (and side effects) allows her to present the roles of both patient and practitioner with confidence. Prinster’s own words and the testimonials of survivors/students weave together personal narratives and proven principles of medicine. Yoga for Cancer is a fully integrative book that works on every level to both motivate and soothe. It deserves to be in the hands of cancer patients everywhere. What are you waiting for? Go and tell a friend!” * Alive Magazine, Helene Meurer, April 2015 *Table of ContentsForeword by Cyndi Lee Foreword by Robyn Frankel-Tiger, M.D. Preface Introduction A Wellness Plan for Survival Part 1Understanding Cancer and the Benefits of Yoga1 My Story 2 The Science of Cancer and Yoga 3 Applying the Science for Recovery and Prevention Part 2How to Build Your Own Yoga Practice4 The y4c (yoga4cancer) Methodology 5 Preparing for Your Practice 6 Creating Your Yoga Practice andLearning the Poses Starting Your Practice Taking Your Seat Finding Dynamic Stillness Taking Time to Breathe A Moment of Meditation Getting Warmed Up Starting to Move with Your Breath Arm Vinyasas Seated Hip and Spine Warm-Ups Warm-Ups on Your Back--Supine Vinyasas Warm-Ups on Hands and Knees Belly-Down Poses--Prone Vinyasas Getting Up and Down Building Strength, Bones, and Balance Standing Poses Sun Salutations Warrior Poses Balancing Acts Rest and Restore Restorative Poses Savasana/Sunset Pose 7 Sample Practices for Varying Stages of Your Treatment and Recovery In Treatment--30 Minutes In Recovery--30 Minutes Maintaining the New Normal--30 Minutes Gaining Strength--30 Minutes In Treatment--60 Minutes In Recovery--60 Minutes Maintaining the New Normal--60 MinutesGaining Strength--60 Minutes Gaining Strength--90 Minutes 8 Poses to Target Common Side Effects Lymphedema Bone Loss Weight Gain Range of Motion/Scar Tissue--Upper Body Range of Motion/Scar Tissue--Lower Body Anxiety/Insomnia Constipation/Bloating/Abdominal Obstruction Detoxification Neuropathy Incontinence Conclusion Cancer Steals Your Breath, Yoga Gives It Back Resources for Survivors, Teachers, and Caretakers Notes Bibliography Index

    Out of stock

    £999.99

  • Handbook of Musculoskeletal Tumors

    SLACK Incorporated Handbook of Musculoskeletal Tumors

    1 in stock

    Book SynopsisA quick-reference handbook with more than 100 figures, charts, and images, Handbook of Musculoskeletal Tumors provides a wide-ranging overview of musculoskeletal tumors for the practicing clinician. From a pathological fracture in the emergency department to a soft tissue tumor in the clinic, musculoskeletal tumors present in clinical practice yet receive minimal exposure in training. Edited by Drs. Matthew T. Wallace and Frank J. Frassica, Handbook of Musculoskeletal Tumors provides readers with concise recommendations for their encounters with diseases including: Latent bone lesions and active and aggressive benign bone lesions Osteosarcoma, Ewing sarcoma, and primary lymphoma of bone Myeloma and metastatic bone disease, chondrosarcoma, osteochondroma, multiple hereditary exostoses, Ollier disease, and Mafucci syndrome Benign soft tissue tumors, including lipomatous tumors, nerve sheath tumors, and myxoid, fibrous, and vascular lesions Soft tissue sarcomas, including undifferentiated pleomorphic sarcoma, liposarcomas, synovial sarcoma, rhabdomyosarcoma, and epithelioid sarcoma Anatomic-specific considerations, including intra-articular lesions and hand, foot, and spine tumors Written for primary care providers, practicing orthopedists and surgeons, residents and students in training, physician assistants, and nurses and nurse practitioners, Handbook of Musculoskeletal Tumors is a practical guide to help practitioners recognize and diagnose suspicious lesions, order appropriate testing, and facilitate prompt referrals to trained musculoskeletal oncologists when appropriate for additional management. Trade Review“This is a great, easy-to-use handbook for practicing clinicians to use in evaluating and clarifying the probable diagnosis of musculoskeletal tumors and when to refer.”© Doody’s Review Service, 2020, Mark R Hutchinson, MD (University of Illinois at Chicago College of Medicine)Table of Contents Section I: Evaluation of Musculoskeletal Tumors Chapter 1: Clinical Presentation of Bone Tumors Chapter 2: Clinical Presentation of Soft-Tissue Tumors Chapter 3: Musculoskeletal Radiology and Imaging of Tumors Chapter 4: Biopsy Chapter 5: Tumor-Mimicking Lesions—Tumor Simulators Section II: Pediatric and Young Adult Bone Tumors Chapter 6: Latent Bone Lesions in Children Chapter 7: Active and Aggressive Benign Bone Lesions in Children and Young Adults Chapter 8: Bone Malignancies in Children and Young Adults Section III: Bone Tumors in Older Adults Chapter 9: Myeloma and Metastatic Bone Disease Chapter 10: Bone Sarcomas in Adults, Chondrosarcoma and Chondrogenic Tumor Syndromes Section IV: Soft-Tissue Tumors Chapter 11: Benign Soft-Tissue Tumors Chapter 12: Soft-Tissue Sarcomas Section V: Anatomic-Specific Considerations Chapter 13: Intra-Articular Lesions Chapter 14: Spine Tumors Chapter 15: Tumors of the Hands and Feet

    1 in stock

    £96.90

  • 90 All Natural Lung Cancer Meal and Juice

    Live Stronger Faster 90 All Natural Lung Cancer Meal and Juice

    1 in stock

    Book Synopsis

    1 in stock

    £18.99

  • 142 Lung Cancer Juice, Salad, and Meal Recipes:

    Live Stronger Faster 142 Lung Cancer Juice, Salad, and Meal Recipes:

    1 in stock

    Book Synopsis

    1 in stock

    £17.99

  • Combination Therapies and their Effectiveness in

    Nova Science Publishers Inc Combination Therapies and their Effectiveness in

    1 in stock

    Book SynopsisThis book highlights up-to-date and novel information with clinical aspects regarding breast cancer. It covers aspects ranging from epidemiology, biology, and molecular classification to currently available and potentially new therapeutic options for breast cancer. It highlights insights into breast cancer at the molecular level with a holistic approach to use combinational strategies involving various therapies for targeting different pathways involved in this particular malignancy. This book contains a range of latest resources, including schematic illustrations, recent reviews, and information for patients with breast cancer. Various novel biomarkers that are under clinical investigation will also be discussed in this book. Furthermore, the relapse and recurrence after treatment with various therapies presents a great problem, as it develops resistance to which combinational strategy may prove to be a promising approach, and in this book, we have discussed all the aspects of combination therapy in breast cancer. People including students, research scholars, educators, pharmaceutical professionals, clinicians, researchers, practitioners and patients as well as their family members will find this book very much useful.Table of ContentsPreface; Dedication; Editors Page; Authors Page; Acknowledgement; An Introduction to Breast Cancer; Novel biomarkers in breast cancer; Therapeutic options for breast cancer; Combination therapy with phytochemicals in breast cancer; Immunotherapy and Chemotherapy in Breast Cancer; Chemotherapy in combination with surgery and radiotherapy in breast cancer; Different drug delivery approaches for breast cancer; Therapeutic landscape of metaplastic breast cancer; Index.

    1 in stock

    £183.59

  • You Can Beat Lung Cancer – Using

    Collective Ink You Can Beat Lung Cancer – Using

    1 in stock

    Book SynopsisCan you overcome lung cancer without harsh chemicals, surgery and debilitation? Are alternative interventions effective? Why do conventional physicians not use them? Can you prevent cancer recurrences and live into old age without chronic diseases and prescribed medications? This book answers these and other questions. This is one of the most comprehensive books available on alternative treatments for lung cancer. It explains the treatments used successfully by a health professional/cancer survivor of 36 years and by some of the leading medical and health practitioners currently in the field. G. Edward Griffin, Author of World Without Cancer, The Politics of Cancer Therapy, and other books and films. Recipient of the Telly Award for Excellence in Television Production. President of American Media.Trade ReviewThis is one of the most comprehensive books available on alternative treatments for lung cancer. It explains the treatments used successfully by a health professional/cancer survivor of 36 years and by some of the leading medical and health practitioners currently in the field. It will be useful, not just for the lay reader, but also for therapists and others with a scientific background. --G. Edward Griffin, Author of World Without Cancer, The Politics of Cancer Therapy, and other books and films. Recipient of the Telly Award for Excellence in Television Production. President of American Media. If you are ever diagnosed with advanced cancer, the odds are very good that your oncologist will tell you that unless you immediately consent to chemotherapy you are going to die. This is a lie! I know, I have been treating conventional chemotherapy failures for years. Other than for leukemia or lymphoma, conventional chemotherapy is almost always a death sentence. There are so many more effective ways to treat advanced cancer, and Dr. Carl Helvie's book, You Can Beat Lung Cancer: Using Alternative/Integrative Interventions, describes some of the most effective. In addition, his book is packed with references and information sources that will help anyone fighting cancer learn more about how to go about it successfully. --Frank Shallenberger, MD, HMD, ABAAM, Medical Director, The Nevada Center of Alternative Medicine, Editor: Real Cures Newsletter and Author This is a valuable piece of writing, to give people hope that there are other ways back to health from cancer, than the 'slash, burn and poison' offered by conventional oncology. --Robert A. Eslinger, D.O., H.M.D. | Medical Director, Reno Integrative Medical Center

    1 in stock

    £15.19

  • A Journey Through Breast Cancer

    Chronos Publishing A Journey Through Breast Cancer

    1 in stock

    Book SynopsisThis book recognises that there are different types and grades of breast cancer plus countless treatment pathways and has been written from a personal perspective, as in the autumn of 2022, I received a diagnosis of Stage 3 Breast Cancer. Everyone travelling the journey will have their own story, I hope that mine helps you.

    1 in stock

    £11.69

  • The Cancer Guide

    Bedford Square Publishers The Cancer Guide

    1 in stock

    Book SynopsisThe Cancer Guide is a definitive and inspirational book designed to help patients, partners, family and work colleagues navigate the trials and difficulties associated with cancer and its treatment.

    1 in stock

    £10.44

  • I Had Cancer, Cancer Never Had Me

    S.H.E. Publishing, LLC I Had Cancer, Cancer Never Had Me

    1 in stock

    1 in stock

    £20.89

  • Handbook of Targeted Cancer Therapy and Immunotherapy: Gastrointestinal Cancer

    Wolters Kluwer Health Handbook of Targeted Cancer Therapy and Immunotherapy: Gastrointestinal Cancer

    1 in stock

    Book SynopsisDesigned for quick, everyday reference, Handbook of Targeted Cancer Therapy and Immunotherapy: Gastrointestinal Cancer provides a practical overview of this rapidly advancing field. Comprehensive yet concise, this easy-access resource by Dr. Milind Javle of MD Anderson Cancer Center and Dr. Mitesh J. Board of Mayo Clinic helps you filter and apply the most recent discoveries as they pertain to specific tumor types, actionable molecular targets, and clinical performance of investigational targeted agents and combinations of agents. Covers gastrointestinal cancer targets—stage 1, 2, and 3 trials and preliminary results, as well as approved therapies. Includes sections on Sequencing Technologies, and Targeted and Immunotherapy Agents. Organizes information by tumor type, pathway, and drug name, so you can approach clinical challenges from any direction. Highlights FDA approvals throughout. Pocket-sized and color coded to help you find information quickly and easily. , Enrich Your eBook Reading Experience Read directly on your preferred device(s), such as computer, tablet, or smartphone. Easily convert to audiobook, powering your content with natural language text-to-speech. ,

    1 in stock

    £46.08

  • Understanding Lung Cancer Anatomical Chart

    Wolters Kluwer Health Understanding Lung Cancer Anatomical Chart

    1 in stock

    Book SynopsisUnderstanding Lung Cancer, Second Edition, defines lung cancer and describes the two main types: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Fully up to date with current guidelines, the chart describes how lung cancer is diagnosed and staged and lists risk factors, signs and symptoms, and treatment options. The main lung image shows the left upper lobe and left lower lobe with metastasis to paratracheal lymph nodes, metastasis to carinal lymph nodes, and a close-up, inset image of a tumor projecting into bronchi. The chart also describes how lung cancer can be prevented, includes a graphic showing how to calculate number of “pack years” along with an image of a cigarette in ashtray and the statistic that approximately 90 percent of lung cancer deaths are related to smoking. Featured sections: Risk Factors Signs and Symptoms Risk Factors Diagnosis and Staging Treatment Options How Can Lung Cancer Be Prevented? What’s a Pack Year? 20" x 26" heavy paper laminated with grommets at top corners

    1 in stock

    £23.37

  • Exercise Oncology: Prescribing Physical Activity

    Springer Nature Switzerland AG Exercise Oncology: Prescribing Physical Activity

    1 in stock

    Book SynopsisThis groundbreaking book presents a unique and practical approach to the evolving field of exercise oncology - the study of physical activity in the context of cancer prevention and control. Presenting the current state of the art, the book is sensibly divided into four thematic sections. Following an opening chapter presenting an overview and timeline of exercise oncology, the chapters comprising part I discuss primary cancer prevention, physical activity and survivorship, and the mechanisms by which these operate. Diagnosis and treatment considerations are discussed in part II, including prehabilitation, exercise during surgical recovery, infusion and radiation therapies, and treatment efficacy. Post-treatment and end-of-life care are covered in part III, including cardio-oncology, energetics and palliative care. Part IV presents behavioral, logistical and policy-making considerations, highlighting a multidisciplinary approach to exercise oncology as well as practical matters such as reimbursement and economics.Written and edited by experts in the field, Exercise Oncology will be a go-to practical resource for sports medicine clinicians, family and primary care physicians, oncologists, physical therapy and rehabilitation specialists, and all medical professionals who treat cancer patients.Table of ContentsChapter 1. Exercise Oncology: Past and Present Kathryn H. SchmitzPart 1 - Physical Activity and Cancer Prevention Chapter 2. Primary PreventionErika Rees-Punia, Alpa V. Patel Chapter 3. Physical Activity and Cancer SurvivalChristine M. Friedenreich, Chelsea R. Stone, Sandra C. Hayes Chapter 4. Mechanisms of Exercise in Cancer Prevention, Treatment and SurvivorshipHannah Savage, Keri L. Schadler Part 2 - From Diagnosis through TreatmentChapter 5. Exercise Oncology from Diagnosis through Treatment: An Overview of Outcomes and ConsiderationsCiaran M. Fairman, Daniel A. GalvãoChapter 6. Prehabilitation: An Emerging Standard in Exercise OncologyNicole L. Stout, Julie K Silver, Jennifer Baima, Sasha E. Knowlton, Xiaorong HuChapter 7. Exercise during Surgical Recovery Rosa M. Pasculli, Jonas Sokolof, Elizabeth Olecki, Kelly Stahl, Niraj GusaniChapter 8. Exercise during Infusion TherapyKristin L. Campbell, Amy KirkhamChapter 9. Exercise During Radiation TherapyJoachim WiskemannChapter 10. Effects of Exercise on Cancer Treatment Completion and EfficacyAndria R. Morielli, Kerry S. Courneya Part 3 – Post-treatment to End of LifeChapter 11. Exercise Oncology from Post-Treatment to End of Life: An Overview of Outcomes and ConsiderationsKira Bloomquist, Sandra C. Hayes Chapter 12. Exercise during Immediate Post-treatment Kerri Winters-Stone, Mary Medysky, Anna L. SchwartzChapter 13. Long-term and Late Effects of Cancer Treatments on Prescribing Physical ActivityAnna L. Schwartz, Jennifer W. Bea, Kerri Winters-StoneChapter 14. Exercise and Cardio-OncologyAmy M. Berkman, Susan C. Gilchrist Chapter 15. Energetics and Cancer OutcomesLeah M. Ferrucci, Melinda L. IrwinChapter 16. Exercise for Advanced Cancers, Metastatic Disease and Palliative CareSonya Lowe, Christopher Sellar, Kirsten Suderman, Margaret L. McNeely Part 4 - Behavior, logistics, and policyChapter 17. Cancer Survivors Becoming and Staying Physically Active: Challenges of Behavior ChangeBernardine M. Pinto, Madison M. Kindred, Chloe GrimmettChapter 18. Making Exercise Standard in Cancer Care Karen Basen-Engquist, Nathan H. ParkerChapter 19. Viewing Exercise Oncology through the Lens of MultidisciplinarityMartijn M. StuiverChapter 20. Policy and Reimbursement Considerations for Exercise Programming in CancerAndrea Cheville, Jennifer Baima, Philip Chang, Charles Mitchell, Stephanie Otto, Sonal Oza, David S. ZuckerChapter 21. Shaping the Future of Exercise OncologyKathryn H. Schmitz

    1 in stock

    £67.49

  • Liver Intra-arterial PRRT with 111In-Octreotide: The Tumoricidal Efficacy of 111In Auger Electron Emission

    Springer Nature Switzerland AG Liver Intra-arterial PRRT with 111In-Octreotide: The Tumoricidal Efficacy of 111In Auger Electron Emission

    1 in stock

    Book SynopsisThis book describes in detail a clinical project that reveals the tumoricidal efficacy of Auger and internal conversion electrons, emitted from n.c.a. 111In and implemented in oncology as a treating armamentarium for peptide receptor radionuclide therapy (PRRT), targeting small size (ø ≤ 20 mm) tumors and micro-metastases.The keen interest in n.c.a. 111In began when it was observed that its Auger electron emission could be highly radiotoxic, due to its high LET when it decayed in the vicinity of cellular DNA. The somatostatin analog octreotide, labeled with [111In-diethylenetriaminepentaacetic acid (DTPA0-D-Phe1)] is an established diagnostic agent for the imaging of somatostatin receptor-positive neuro- (or non-neuro) endocrine tumors. It relies on receptor-mediated binding, internalization and installation in the lysosomes in the proximity of the nucleus; administered in large doses, loco-regionally, via the feeding artery of solid tumors, can be highly radiotoxic if they over-express somatostatin receptors, mainly of the sst2 histotype.The book compares the results between i.v. and i.a. implementation in more than 80 patients after over 800 i.a. infusions in neuroendocrine tumors, meningiomas, paragangliomas and colorectal carcinomas in a single Institute (Aretaieion University Hospital) and encourages the i.a. way, leading to “tumor melting”, while minimizing the toxicity to healthy peritumoral liver tissue and critical organs (kidneys and bone marrow).The volume is an invaluable tool for nuclear medicine physicians, interventional radiologists and oncologists dealing with radiopeptide therapies. Table of ContentsThe efficacy of auger and internal conversion electron emission 0f in-111 to treat neuroendocrine tumors.- Somatostatin.- Gastro-entero-pancreatic neuroendocrine tumors.- [111in-dtpa0-d-phe1] - octreotide: the ligand -the receptor-label.- Regulations and requirements of hospitals performing radio-infusions.- Intravenous radio-peptide infusion with in-octreotide.- Intra-arterial radio-peptide infusion.- Radio-peptide infusions after implementation of an intra-arterial port system.- US, CT and MRI for the evaluation of patients with neuroendocrine tumors.- Angiographic anatomy on the course of liver intra-arterial infusion.- Liver radio-infusions: identifying anatomic variants.- Dosimetry and dose calculation: its necessity in radio-peptide therapy.- Evaluation and assessment of the radio-peptide treatment efficacy.- Intra-venous radio-peptide infusions with in-octreotide for the treatment of bronchial carcinoids.- Intra-arterial radio - peptide infusions for the treatment of colorectal carcinomas.- Intra-arterial radio-peptide infusions for the treatment of paragangliomas.- Intra-arterial radio-peptide infusions for the treatment of brain meningiomas.- Surgery in neuroendocrine tumors.- Cytoreductive surgery combined with intraperitoneal [111in-dtpa0– d-phe1]-octreotide infusions in neuroendocrine character metastases.- Patients survival followed intra-arterial versus intravenous infusions.- Complications and side effects on the course of liver-radio-infusions.- Progression free survival and response rate in neuroendocrine liver–metastasized patients, treated with in-111 octreotide.- Therapy response vs variability of tumor size, absorbed dose, and ki-67 index after in-111 octreotide intra-arterial infusions.

    1 in stock

    £71.99

  • Epigenetics in Oncology

    Springer International Publishing AG Epigenetics in Oncology

    1 in stock

    Book SynopsisThis book addresses Epigenetics in Cancer and covers the most recent advances in RNA/histone/DNA epigenetics in Oncology. RNA/histone/DNA epigenetics have been shown to play pivotal roles in cancer initiation, progression, maintenance and drug response/resistance, tumor microenvironment, cancer stem cell self-renewal, cancer metabolism, and tumor immune evasion. In particular, research in RNA cancer epigenetics has made impressive progress in the last few years.Individual chapters in Part I (focusing on RNA epigenetics) are devoted to RNA modifications in Cancer Metabolism and Microenvironment, Cancer Stem Cell Biology, Immune Surveillance, Solid Tumors and Tumor Immunity, and Hematopoietic Malignancies, as well as to RNA editing in Cancer. Chapters in Part II and III of the book focus on histone epigenetics and DNA epigenetics, respectively.By familiarizing readers with the latest developments in this complex and challenging field, the book offers a valuable resource for scientists, graduate students and clinicians alike. Table of ContentsPART I RNA EpigeneticsRNA modifications in cancer metabolism and tumor microenvironmentRNA modifications in cancer stem cell biologyRecent advances of RNA m6A modifications in cancer immunoediting and immunotherapyRecent advances in RNA m6A modification in solid tumors and tumor immunityRecent advances in adenosine-to-inosine RNA editing in cancerRNA modification in hematopoietic malignanciesPART II Histone EpigeneticsThe SWI/SNF complex: A frequently-mutated chromatin remodelling complex in cancerHistone readers and their roles in cancerPolycomb repressive complex 2 in oncologyEpigenetic (de)regulation in prostate cancerPART III DNA Epigenetics TET methylcytosine dioxygenases in cancerInferring the cancer cellular epigenome heterogeneity via DNA methylation patterns

    1 in stock

    £98.99

  • A Guide to Breast Cancer Research

    Springer A Guide to Breast Cancer Research

    1 in stock

    Book SynopsisPart I: Development and cancer: basic concepts.- Chapter 1: Introductory chapter by Sorlie and Clarke.- Chapter 2: Embryonic mammary gland morphogenesis.- Chapter 3: Breast morphogenesis: from normal development to cancer.- Chapter 4: Single-Cell Analysis in the Mouse and Human Mammary Gland.- Part II: Development and cancer: model systems and approaches.- Chapter 5: Recording lineage history with cellular barcodes in the mammary epithelium and in breast cancer.- Chapter 6: Models for studying ductal carcinoma in situ progression.- Chapter 7: Patient-derived xenografts of breast cancer.- Chapter 8: Rat Models of Breast Cancer.- Part III: Development and cancer: cells of origin and heterogeneity.- Chapter 9: Cells of origin of breast cancer and intertumoral heterogeneity.- Chapter 10: Mechanisms of regulation of cell fate in breast development and cancer.- Chapter 11: Classification of breast cancer through the perspective of cell identity models.- Part IV:  Cellular and molecular basis.- Chapter 12: The Microenvironment in DCIS and its Role in Disease Progression.- Chapter 13: Molecular basis of breast tumor heterogeneity.- Chapter 14: E-cadherin-mediated cell-cell adhesion and invasive lobular breast cancer.- Part V: Signalling pathways.- Chapter 15: Hormone signaling in breast development and cancer.- Chapter 16: RANK/RANKL signaling pathway in breast development and cancer.- Chapter 17: Metabolic Reprogramming and Adaption in Breast Cancer Progression and Metastasis.- Part VI: Metastasis and immunity.- Chapter 18: Microenvironmental regulation of dormancy in breast cancer metastasis: An ally that changes allegiances.- Chapter 19: The Roles of Myeloid Cells in Breast Cancer Progression.- Chapter 20: Immune microenvironment in breast cancer metastasis.- Part VII:  Subtypes, treatment and resistance.- Chapter 21: Clinical Implications of Breast Cancer Intrinsic Subtypes.- Chapter 22: Targeting Estrogen Receptor signalling in breast cancer therapy.- Chapter 23: CDK4/6 inhibitor resistance in ER+ breast cancer.- Chapter 24: HER2-positive breast cancer treatment and resistance.

    1 in stock

    £141.80

© 2026 Book Curl

    • American Express
    • Apple Pay
    • Diners Club
    • Discover
    • Google Pay
    • Maestro
    • Mastercard
    • PayPal
    • Shop Pay
    • Union Pay
    • Visa

    Login

    Forgot your password?

    Don't have an account yet?
    Create account